Retreatment of Exudative Age-Related Macular Degeneration after Loading 3-Monthly Intravitreal Ranibizumab

Conclusions: Age and the T allele ofARMS2A69S are the risk factors requiring retreatments, leading to poor visual change in eyes with exudative AMD following the initial 3-monthly IVR.Ophthalmologica
Source: Ophthalmologica - Category: Opthalmology Source Type: research